BIT 3.03% 3.4¢ biotron limited

Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-579

  1. 405 Posts.
    lightbulb Created with Sketch. 39

    Bit 225 could be an important step which should be explored. As for reducing viral loads -cART is gold standard as one can’t use mono therapy even if BIT 225 would have lowered viral load.... risk of resistance would be too high with single drug regimen. 

    BIT 225 could be added ( if proven worthy) to cART.

    soecially in early most stages of HIV

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
0.001(3.03%)
Mkt cap ! $30.67M
Open High Low Value Volume
3.4¢ 3.4¢ 3.3¢ $632 18.85K

Buyers (Bids)

No. Vol. Price($)
1 287617 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 37989 2
View Market Depth
Last trade - 13.36pm 19/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.